Insight

Rafeh Naqash: Important data in the field of toxicities

Photo from Rafeh Naqash/Twitter

Nov 27, 2023, 16:52

Rafeh Naqash: Important data in the field of toxicities

Quoting Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Center, on X/Twitter:

”Hot off the press now in The Lancet Oncology, led by Yu Fujiwara with an excellent team Amin Nassar, Elio Adib, Zain Ul Abideen Asad, Nobuyuki Horita and Susu Zhou. Thank you The Lancet Oncology teams for the editorial support. OU Health Stephenson Cancer Center, Sarah Cannon Docs. Also read commentary!!

Important data in the field of toxicities balancing risk vs benefit and encouraging NEED for multi D care of these individuals getting immunotherapy in the earlier stage setting!”

For the article click here.
Source: Rafeh Naqash/Twitter

Amin Nassar cancer Elio Adib Immune Checkpoint Inhibitors immunotherapy OncoDaily Oncology OU Health Stephenson Cancer Center Rafeh Naqash Sarah Cannon Docs The Lancet Oncology Yu Fujiwara Zain Ul Abideen Asad

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage